All Clinical Trials

Clinical Trial NCT04649242

Phase 3, multicenter, randomized, double-blind, group sequential, placebo-controlled study to assess efficacy and safety of rimegepant for the treatment of migraine (with or without aura) in children and adolescents 6 to 18 years of age

  • ClinicalTrials.gov ID: NCT04649242
  • Not accepting healthy volunteers
  • UTSW Principal Investigator: DERYK LEE WALSH

summary

nada!

objective

N/A

If you are interested in this clinical trial, please contact Christina Howard on the Children’s Health Research Team.Call 214-456-8559Email